|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sastre J, Argiles G, Benavides M, Feliu J,
Garcia-Alfonso P, Garcia-Carbonero R, Grávalos C, Guillén-Ponce C,
Martínez-Villacampa M and Pericay C: Clinical management of
regorafenib in the treatment of patients with advanced colorectal
cancer. Clin Transl Oncol. 16:942–953. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ye LC, Liu TS, Ren L, Wei Y, Zhu DX, Zai
SY, Ye QH, Yu Y, Xu B, Qin XY, et al: Randomized controlled trial
of cetuximab plus chemotherapy for patients with KRAS wild-type
unresectable colorectal liver-limited metastases. J Clin Oncol.
31:1931–1938. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yuan ZX, Wang XY, Qin QY, Chen DF, Zhong
QH, Wang L and Wang JP: The prognostic role of BRAF mutation in
metastatic colorectal cancer receiving anti-EGFR monoclonal
antibodies: A meta-analysis. PLoS One. 8:e659952013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Le DT, Uram JN, Wang H, Bartlett BR,
Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, et
al: PD-1 blockade in tumors with mismatch-repair deficiency. N Engl
J Med. 372:2509–2520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grady WM and Markowitz SD: The molecular
pathogenesis of colorectal cancer and its potential application to
colorectal cancer screening. Dig Dis Sci. 60:762–772. 2015.
View Article : Google Scholar
|
|
7
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long non-coding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qi P, Xu MD, Ni SJ, Huang D, Wei P, Tan C,
Zhou XY and Du X: Low expression of LOC285194 is associated with
poor prognosis in colorectal cancer. J Transl Med. 11:1222013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X, Wu Z, Fu X and Han W: Long
non-coding RNAs: Insights from biological features and functions to
diseases. Med Res Rev. 33:517–553. 2013. View Article : Google Scholar
|
|
11
|
Yang F, Zhang L, Huo XS, Yuan JH, Xu D,
Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ, et al: Long non-coding
RNA high expression in hepatocellular carcinoma facilitates tumor
growth through enhancer of zeste homolog 2 in humans. Hepatology.
54:1679–1689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF, et al: The lncRNA H19
promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ni B, Yu X, Guo X, Fan X, Yang Z, Wu P,
Yuan Z, Deng Y, Wang J, Chen D, et al: Increased urothelial cancer
associated 1 is associated with tumor proliferation and metastasis
and predicts poor prognosis in colorectal cancer. Int J Oncol.
47:1329–1338. 2015.PubMed/NCBI
|
|
14
|
Kogo R, Shimamura T, Mimori K, Kawahara K,
Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al:
Long non-coding RNA HOTAIR regulates polycomb-dependent chromatin
modification and is associated with poor prognosis in colorectal
cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiu JJ and Yan JB: Long non-coding RNA
LINC01296 is a potential prognostic biomarker in patients with
colorectal cancer. Tumour Biol. 36:7175–83. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang F, Yuan JH, Wang SB, Yang F, Yuan SX,
Ye C, Yang N, Zhou WP, Li WL, Li W, et al: Oncofetal long
non-coding RNA PVT1 promotes proliferation and stem cell-like
property of hepatocellular carcinoma cells by stabilizing NOP2.
Hepatology. 60:1278–1290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ghahhari NM and Babashah S: Interplay
between microRNAs and WNT/β-catenin signalling pathway regulates
epithelial-mesenchymal transition in cancer. Eur J Cancer.
51:1638–1649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun NX, Ye C, Zhao Q, Zhang Q, Xu C, Wang
SB, Jin ZJ, Sun SH, Wang F and Li W: Long non-coding RNA-EBIC
promotes tumor cell invasion by binding to EZH2 and repressing
E-cadherin in cervical cancer. PLoS One. 9:e1003402014. View Article : Google Scholar
|
|
19
|
Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu
J: Long non-coding RNA H19 increases bladder cancer metastasis by
associating with EZH2 and inhibiting E-cadherin expression. Cancer
Lett. 333:213–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long non-coding
RNA activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deng Q, He B, Gao T, Pan Y, Sun H, Xu Y,
Li R, Ying H, Wang F, Liu X, et al: Up-regulation of 91H promotes
tumor metastasis and predicts poor prognosis for patients with
colorectal cancer. PLoS One. 9:e1030222014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi D, Zheng H, Zhuo C, Peng J, Li D, Xu
Y, Li X, Cai G and Cai S: Low expression of novel lncRNA
RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal
cancer. Med Oncol. 31:312014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yin D, He X, Zhang E, Kong R, De W and
Zhang Z: Long non-coding RNA GAS5 affects cell proliferation and
predicts a poor prognosis in patients with colorectal cancer. Med
Oncol. 31:2532014. View Article : Google Scholar
|
|
24
|
Kam Y, Rubinstein A, Naik S, Djavsarov I,
Halle D, Ariel I, Gure AO, Stojadinovic A, Pan H, Tsivin V, et al:
Detection of a long non-coding RNA (CCAT1) in living cells and
human adeno-carcinoma of colon tissues using FIT-PNA molecular
beacons. Cancer Lett. 352:90–96. 2014. View Article : Google Scholar
|
|
25
|
Yan B, Gu W, Yang Z, Gu Z, Yue X, Gu Q and
Liu L: Downregulation of a long non-coding RNA-ncRuPAR contributes
to tumor inhibition in colorectal cancer. Tumour Biol.
35:11329–11335. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L,
Jiang H, Ren J, Cai J and Li Q: Resveratrol suppresses
epithelial-to-mesenchymal transition in colorectal cancer through
TGF-β1/Smads signaling pathway mediated Snail/E-cadherin
expression. BMC Cancer. 15:972015. View Article : Google Scholar
|
|
27
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View
Article : Google Scholar
|
|
28
|
Vincan E and Barker N: The upstream
components of the Wnt signalling pathway in the dynamic EMT and MET
associated with colorectal cancer progression. Clin Exp Metastasis.
25:657–663. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin JJ, Zhao TZ, Cai WK, Yang YX, Sun C,
Zhang Z, Xu YQ, Chang T and Li ZY: Inhibition of histamine receptor
3 suppresses glioblastoma tumor growth, invasion, and
epithelial-to-mesenchymal transition. Oncotarget. 6:17107–17120.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang L, Sun J, Wang B, Ren JC, Su W and
Zhang T: MicroRNA-10b triggers the epithelial-mesenchymal
transition (EMT) of laryngeal carcinoma Hep-2 cells by directly
targeting the E-cadherin. Appl Biochem Biotechnol. 176:33–44. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi C, Yang X, Ni Y, Hou N, Xu L, Zhan F,
Zhu H, Xiong L and Chen P: High Rab27A expression indicates
favorable prognosis in CRC. Diagn Pathol. 10:682015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu S, Yu Y, Sun Y, Wang X, Luo R, Zhao N,
Zhang W, Li Q, Cui Y, Wang Y, et al: Activation of FOXO3a suggests
good prognosis of patients with radically resected gastric cancer.
Int J Clin Exp Pathol. 8:2963–2970. 2015.PubMed/NCBI
|
|
33
|
Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang
Y, Tang GN, Zhou WP and Sun SH: Hepatitis B virus X protein
(HBx)-related long non-coding RNA (lncRNA) down-regulated
expression by HBx (Dreh) inhibits hepatocellular carcinoma
metastasis by targeting the intermediate filament protein vimentin.
Hepatology. 57:1882–1892. 2013. View Article : Google Scholar
|
|
34
|
Hoshino A, Costa-Silva B, Shen TL,
Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di
Giannatale A, Ceder S, et al: Tumour exosome integrins determine
organotropic metastasis. Nature. 527:329–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fang JH, Zhou HC, Zhang C, Shang LR, Zhang
L, Xu J, Zheng L, Yuan Y, Guo RP, Jia WH, et al: A novel vascular
pattern promotes metastasis of hepatocellular carcinoma in an
epithelial-mesenchymal transition-independent manner. Hepatology.
62:452–465. 2015. View Article : Google Scholar : PubMed/NCBI
|
